论文信息 - Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen - 字舞流文

Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

D. Rea | M. Campone | J. Beck | M. Aglietta | E. Alba | R. López | L. Biganzoli | A. Kong | Samreen I. Ahmed | A. Armstrong | Soo-Chin Lee | S. H. Schmitz | C. Lefebvre | M. Akimov | S. F. Schmitz | Samreen Ahmed